Form 8-K - Current report:
SEC Accession No. 0001213900-25-007522
Filing Date
2025-01-28
Accepted
2025-01-28 16:01:18
Documents
13
Period of Report
2025-01-28
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0228998-8k_pmgc.htm   iXBRL 8-K 27743
  Complete submission text file 0001213900-25-007522.txt   206682

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE elab-20250128.xsd EX-101.SCH 3027
3 XBRL LABEL FILE elab-20250128_lab.xml EX-101.LAB 34916
4 XBRL PRESENTATION FILE elab-20250128_pre.xml EX-101.PRE 22797
15 EXTRACTED XBRL INSTANCE DOCUMENT ea0228998-8k_pmgc_htm.xml XML 3965
Mailing Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660
Business Address 120 NEWPORT CENTER DRIVE STE 250 NEWPORT BEACH CA 92660 888-445-4886
PMGC Holdings Inc. (Filer) CIK: 0001840563 (see all company filings)

EIN.: 851399981 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41875 | Film No.: 25564053
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)